ID   HCN1_MOUSE              Reviewed;         910 AA.
AC   O88704; O54899; Q9D613;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   07-APR-2021, entry version 186.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 1 {ECO:0000303|PubMed:9405696};
DE            Short=BCNG-1 {ECO:0000303|PubMed:9405696};
DE   AltName: Full=Hyperpolarization-activated cation channel 2 {ECO:0000303|PubMed:9634236};
DE            Short=HAC-2 {ECO:0000303|PubMed:9634236};
GN   Name=Hcn1; Synonyms=Bcng1 {ECO:0000303|PubMed:9405696}, Hac2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, GLYCOSYLATION, AND
RP   INTERACTION WITH CSK.
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=9405696; DOI=10.1073/pnas.94.26.14815;
RA   Santoro B., Grant S.G.N., Bartsch D., Kandel E.R.;
RT   "Interactive cloning with the SH3 domain of N-src identifies a new brain
RT   specific ion channel protein, with homology to eag and cyclic nucleotide-
RT   gated channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14815-14820(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=9634236; DOI=10.1038/31255;
RA   Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M.;
RT   "A family of hyperpolarization-activated cation channels.";
RL   Nature 393:587-591(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 377-910.
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ACTIVITY REGULATION.
RX   PubMed=9630217; DOI=10.1016/s0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R., Siegelbaum S.A.,
RA   Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [5]
RP   INTERACTION WITH KCNE2.
RX   PubMed=11420311; DOI=10.1161/hh1201.093511;
RA   Yu H., Wu J., Potapova I., Wymore R.T., Holmes B., Zuckerman J., Pan Z.,
RA   Wang H., Shi W., Robinson R.B., El-Maghrabi M.R., Benjamin W., Dixon J.E.,
RA   McKinnon D., Cohen I.S., Wymore R.;
RT   "MinK-related peptide 1: a beta subunit for the HCN ion channel subunit
RT   family enhances expression and speeds activation.";
RL   Circ. Res. 88:E84-E87(2001).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ACTIVITY REGULATION.
RX   PubMed=11459060; DOI=10.1038/35081088;
RA   Wainger B.J., DeGennaro M., Santoro B., Siegelbaum S.A., Tibbs G.R.;
RT   "Molecular mechanism of cAMP modulation of HCN pacemaker channels.";
RL   Nature 411:805-810(2001).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11675786; DOI=10.1038/35098087;
RA   Stevens D.R., Seifert R., Bufe B., Mueller F., Kremmer E., Gauss R.,
RA   Meyerhof W., Kaupp U.B., Lindemann B.;
RT   "Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to
RT   sour stimuli.";
RL   Nature 413:631-635(2001).
RN   [8]
RP   INTERACTION WITH HCN2, AND MUTAGENESIS OF GLY-349; TYR-350 AND GLY-351.
RX   PubMed=12089064; DOI=10.1161/01.res.0000024390.97889.c6;
RA   Xue T., Marban E., Li R.A.;
RT   "Dominant-negative suppression of HCN1- and HCN2-encoded pacemaker currents
RT   by an engineered HCN1 construct: insights into structure-function
RT   relationships and multimerization.";
RL   Circ. Res. 90:1267-1273(2002).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH HCN2.
RX   PubMed=12034718; DOI=10.1074/jbc.m200504200;
RA   Proenza C., Tran N., Angoli D., Zahynacz K., Balcar P., Accili E.A.;
RT   "Different roles for the cyclic nucleotide binding domain and amino
RT   terminus in assembly and expression of hyperpolarization-activated, cyclic
RT   nucleotide-gated channels.";
RL   J. Biol. Chem. 277:29634-29642(2002).
RN   [10]
RP   MUTAGENESIS OF CYS-303 AND CYS-318.
RX   PubMed=12351622; DOI=10.1074/jbc.m204915200;
RA   Xue T., Li R.A.;
RT   "An external determinant in the S5-P linker of the pacemaker (HCN) channel
RT   identified by sulfhydryl modification.";
RL   J. Biol. Chem. 277:46233-46242(2002).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 390-592 IN COMPLEX WITH CAMP,
RP   FUNCTION, SUBCELLULAR LOCATION, NUCLEOTIDE-BINDING, ACTIVITY REGULATION,
RP   MUTAGENESIS OF ARG-538, AND SUBUNIT.
RX   PubMed=22006928; DOI=10.1074/jbc.m111.297606;
RA   Lolicato M., Nardini M., Gazzarrini S., Moller S., Bertinetti D.,
RA   Herberg F.W., Bolognesi M., Martin H., Fasolini M., Bertrand J.A.,
RA   Arrigoni C., Thiel G., Moroni A.;
RT   "Tetramerization dynamics of C-terminal domain underlies isoform-specific
RT   cAMP gating in hyperpolarization-activated cyclic nucleotide-gated
RT   channels.";
RL   J. Biol. Chem. 286:44811-44820(2011).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the native
CC       pacemaker currents in heart (If) and in neurons (Ih). May mediate
CC       responses to sour stimuli. {ECO:0000269|PubMed:11459060,
CC       ECO:0000269|PubMed:11675786, ECO:0000269|PubMed:12034718,
CC       ECO:0000269|PubMed:22006928, ECO:0000269|PubMed:9630217}.
CC   -!- ACTIVITY REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding causes a conformation change
CC       that leads to the assembly of an active tetramer and channel opening.
CC       Compared to other family members, cAMP has less stimulatory effect on
CC       HCN1 because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low. {ECO:0000269|PubMed:11459060,
CC       ECO:0000269|PubMed:22006928, ECO:0000269|PubMed:9630217}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN2. The potassium channel
CC       is composed of a homo- or heterotetrameric complex of pore-forming
CC       subunits. Interacts with KCNE2. Interacts with the SH3 domain of CSK
CC       (PubMed:9405696). {ECO:0000269|PubMed:11420311,
CC       ECO:0000269|PubMed:12034718, ECO:0000269|PubMed:12089064,
CC       ECO:0000269|PubMed:22006928, ECO:0000269|PubMed:9405696}.
CC   -!- INTERACTION:
CC       O88704; O88704: Hcn1; NbExp=2; IntAct=EBI-8766347, EBI-8766347;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11459060,
CC       ECO:0000269|PubMed:22006928, ECO:0000269|PubMed:9630217}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:11459060,
CC       ECO:0000269|PubMed:22006928, ECO:0000269|PubMed:9630217}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain. Highly expressed
CC       in apical dendrites of pyramidal neurons in the cortex, in the layer
CC       corresponding to the stratum lacunosum-moleculare in the hippocampus
CC       and in axons of basket cells in the cerebellum. Expressed in a subset
CC       of elongated cells in taste buds. {ECO:0000269|PubMed:11675786,
CC       ECO:0000269|PubMed:9405696}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000250|UniProtKB:O60741}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:9405696}.
CC   -!- MISCELLANEOUS: Inhibited by extracellular cesium ions.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK014722; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF028737; AAC53518.1; -; mRNA.
DR   EMBL; AJ225123; CAA12407.1; -; mRNA.
DR   EMBL; AK014722; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS26793.1; -.
DR   RefSeq; NP_034538.2; NM_010408.3.
DR   PDB; 3U0Z; X-ray; 2.90 A; A/B=390-592.
DR   PDBsum; 3U0Z; -.
DR   SMR; O88704; -.
DR   BioGRID; 200252; 39.
DR   ComplexPortal; CPX-260; HCN1 channel complex.
DR   IntAct; O88704; 39.
DR   STRING; 10090.ENSMUSP00000006991; -.
DR   BindingDB; O88704; -.
DR   ChEMBL; CHEMBL1250401; -.
DR   DrugCentral; O88704; -.
DR   GuidetoPHARMACOLOGY; 400; -.
DR   TCDB; 1.A.1.5.2; the voltage-gated ion channel (vic) superfamily.
DR   GlyGen; O88704; 1 site.
DR   iPTMnet; O88704; -.
DR   PhosphoSitePlus; O88704; -.
DR   SwissPalm; O88704; -.
DR   MaxQB; O88704; -.
DR   PaxDb; O88704; -.
DR   PeptideAtlas; O88704; -.
DR   PRIDE; O88704; -.
DR   ProteomicsDB; 269769; -.
DR   ABCD; O88704; 1 sequenced antibody.
DR   Antibodypedia; 23274; 363 antibodies.
DR   Ensembl; ENSMUST00000006991; ENSMUSP00000006991; ENSMUSG00000021730.
DR   GeneID; 15165; -.
DR   KEGG; mmu:15165; -.
DR   UCSC; uc007ryo.2; mouse.
DR   CTD; 348980; -.
DR   MGI; MGI:1096392; Hcn1.
DR   eggNOG; KOG0498; Eukaryota.
DR   GeneTree; ENSGT00940000158207; -.
DR   HOGENOM; CLU_005746_15_1_1; -.
DR   InParanoid; O88704; -.
DR   OMA; VHRSTQA; -.
DR   OrthoDB; 281394at2759; -.
DR   PhylomeDB; O88704; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-MMU-1296061; HCN channels.
DR   BioGRID-ORCS; 15165; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Hcn1; mouse.
DR   PRO; PR:O88704; -.
DR   Proteomes; UP000000589; Chromosome 13.
DR   RNAct; O88704; protein.
DR   Bgee; ENSMUSG00000021730; Expressed in retina and 137 other tissues.
DR   Genevisible; O88704; MM.
DR   GO; GO:0097440; C:apical dendrite; ISO:MGI.
DR   GO; GO:0030424; C:axon; IDA:MGI.
DR   GO; GO:0043679; C:axon terminus; ISO:MGI.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; IDA:MGI.
DR   GO; GO:0032590; C:dendrite membrane; ISO:MGI.
DR   GO; GO:0043198; C:dendritic shaft; ISO:MGI.
DR   GO; GO:0098855; C:HCN channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0036477; C:somatodendritic compartment; ISO:MGI.
DR   GO; GO:0045202; C:synapse; ISO:MGI.
DR   GO; GO:0030552; F:cAMP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005222; F:intracellular cAMP-activated cation channel activity; IMP:UniProtKB.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISO:MGI.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISO:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISO:MGI.
DR   GO; GO:0045176; P:apical protein localization; IMP:MGI.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:UniProtKB.
DR   GO; GO:0045759; P:negative regulation of action potential; ISO:MGI.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; ISO:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:0003254; P:regulation of membrane depolarization; ISO:MGI.
DR   GO; GO:1902630; P:regulation of membrane hyperpolarization; ISO:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:MGI.
DR   GO; GO:0051592; P:response to calcium ion; ISO:MGI.
DR   GO; GO:0046549; P:retinal cone cell development; IMP:MGI.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:MGI.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.20.120.350; -; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR45689:SF3; PTHR45689:SF3; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..910
FT                   /note="Potassium/sodium hyperpolarization-activated cyclic
FT                   nucleotide-gated channel 1"
FT                   /id="PRO_0000054108"
FT   TOPO_DOM        1..131
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TRANSMEM        132..153
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        154..162
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TRANSMEM        163..183
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        184..204
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TRANSMEM        205..225
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        226..249
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TRANSMEM        250..270
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        271..284
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TRANSMEM        285..307
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        308..333
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   INTRAMEM        334..355
FT                   /note="Pore-forming; Name=Segment H5"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        356..360
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TRANSMEM        361..381
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   TOPO_DOM        382..910
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   NP_BIND         528..531
FT                   /note="cAMP"
FT                   /evidence="ECO:0000269|PubMed:22006928,
FT                   ECO:0007744|PDB:3U0Z"
FT   NP_BIND         538..539
FT                   /note="cAMP"
FT                   /evidence="ECO:0000269|PubMed:22006928,
FT                   ECO:0007744|PDB:3U0Z"
FT   NP_BIND         579..582
FT                   /note="cAMP"
FT                   /evidence="ECO:0000269|PubMed:22006928,
FT                   ECO:0007744|PDB:3U0Z"
FT   REGION          1..82
FT                   /note="Intrinsically disordered"
FT                   /evidence="ECO:0000250|UniProtKB:O60741"
FT   MOTIF           347..351
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000305|PubMed:12089064"
FT   COMPBIAS        1..81
FT                   /note="Gly-rich"
FT   COMPBIAS        715..777
FT                   /note="Gln-rich"
FT   COMPBIAS        878..884
FT                   /note="Poly-Pro"
FT   CARBOHYD        327
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:9405696"
FT   MUTAGEN         303
FT                   /note="C->S: Abolishes conductivity."
FT                   /evidence="ECO:0000269|PubMed:12351622"
FT   MUTAGEN         318
FT                   /note="C->S: Abolishes sensitivity to sulfhydryl
FT                   modification."
FT                   /evidence="ECO:0000269|PubMed:12351622"
FT   MUTAGEN         349
FT                   /note="G->A: Abolishes conductivity; when associated with
FT                   A-350 and A-351."
FT                   /evidence="ECO:0000269|PubMed:12089064"
FT   MUTAGEN         350
FT                   /note="Y->A: Abolishes conductivity; when associated with
FT                   A-349 and A-351."
FT                   /evidence="ECO:0000269|PubMed:12089064"
FT   MUTAGEN         351
FT                   /note="G->A: Abolishes conductivity; when associated with
FT                   A-349 and A-350."
FT                   /evidence="ECO:0000269|PubMed:12089064"
FT   MUTAGEN         538
FT                   /note="R->E: Reduces affinity for cAMP and impairs
FT                   tetramerization."
FT                   /evidence="ECO:0000269|PubMed:22006928"
FT   CONFLICT        42
FT                   /note="G -> R (in Ref. 1; AAC53518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        394
FT                   /note="R -> S (in Ref. 3; AK014722)"
FT                   /evidence="ECO:0000305"
FT   HELIX           391..410
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           414..428
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           435..440
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           444..454
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           456..460
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           463..466
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           470..478
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          481..485
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          490..492
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          500..506
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          509..512
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          519..521
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          526..528
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           529..534
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          540..546
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   STRAND          548..554
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           555..564
FT                   /evidence="ECO:0007744|PDB:3U0Z"
FT   HELIX           567..583
FT                   /evidence="ECO:0007744|PDB:3U0Z"
SQ   SEQUENCE   910 AA;  102432 MW;  56FD5F328DD972E9 CRC64;
     MEGGGKPNSA SNSRDDGNSV FPSKAPATGP VAADKRLGTP PGGGAAGKEH GNSVCFKVDG
     GGGEEPAGSF EDAEGPRRQY GFMQRQFTSM LQPGVNKFSL RMFGSQKAVE KEQERVKTAG
     FWIIHPYSDF RFYWDLIMLI MMVGNLVIIP VGITFFTEQT TTPWIIFNVA SDTVFLLDLI
     MNFRTGTVNE DSSEIILDPK VIKMNYLKSW FVVDFISSIP VDYIFLIVEK GMDSEVYKTA
     RALRIVRFTK ILSLLRLLRL SRLIRYIHQW EEIFHMTYDL ASAVVRIFNL IGMMLLLCHW
     DGCLQFLVPL LQDFPPDCWV SLNEMVNDSW GKQYSYALFK AMSHMLCIGY GAQAPVSMSD
     LWITMLSMIV GATCYAMFVG HATALIQSLD SSRRQYQEKY KQVEQYMSFH KLPADMRQKI
     HDYYEHRYQG KIFDEENILS ELNDPLREEI VNFNCRKLVA TMPLFANADP NFVTAMLSKL
     RFEVFQPGDY IIREGAVGKK MYFIQHGVAG VITKSSKEMK LTDGSYFGEI CLLTKGRRTA
     SVRADTYCRL YSLSVDNFNE VLEEYPMMRR AFETVAIDRL DRIGKKNSIL LQKFQKDLNT
     GVFNNQENEI LKQIVKHDRE MVQAIPPINY PQMTALNCTS STTTPTSRMR TQSPPVYTAT
     SLSHSNLHSP SPSTQTPQPS AILSPCSYTT AVCSPPIQSP LATRTFHYAS PTASQLSLMQ
     QPQQQLPQSQ VQQTQTQTQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQPQTPG
     SSTPKNEVHK STQALHNTNL TKEVRPLSAS QPSLPHEVST LISRPHPTVG ESLASIPQPV
     AAVHSTGLQA GSRSTVPQRV TLFRQMSSGA IPPNRGVPPA PPPPAAVQRE SPSVLNTDPD
     AEKPRFASNL
//
